ArticleFrontiers in medicine2025
Blood indicators for short-term mortality risk in older patients with hip fracture: association and predictive value.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To investigate blood indicators associated with short-term mortality risk in older patients with hip fracture, and further evaluate the incremental predictive value of incorporating these indicators into existing clinical models. Methods: Data from 1881 patients in our institutional hip fracture database between January 2013 and December 2023 were retrospectively analyzed. The study outcome was all-cause mortality within 90 days of admission. Stepwise logistic regression, the Boruta algorithm, and Lasso regression were performed to identify features associated with mortality risk. Following feature selection, two predictive models were developed: Model A (clinical indicators only) and Model B (both clinical and blood indicators). Predictive performance was assessed using the area under the curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: Of the 1881 patients, 217 (11.5%) died within 90 days. Stepwise logistic regression identified 12 significant features associated with mortality risk, the Boruta algorithm identified 25 important features, and Lasso regression analysis selected 18 features with non-zero coefficients (all Conclusion: Various blood indicators were associated with 90-day mortality in older patients with hip fracture, and significantly enhanced the predictive ability of clinical models for short-term mortality risk. By utilizing these blood indicators, clinicians can comprehensively and objectively assess the physiological status of hip fracture patients at admission, thereby facilitating the early identification of high-risk patients and guiding personalized treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.